COBALT

Serial Number 90722349
606

Registration Progress

Application Filed
May 19, 2021
Under Examination
Apr 19, 2022
Approved for Publication
Feb 22, 2022
Published for Opposition
Feb 22, 2022
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: COBALT
Previous Owner: Crispr Therapeutics AG
Classes: 005, 042

Trademark Image

COBALT

Basic Information

Serial Number
90722349
Filing Date
May 19, 2021
Published for Opposition
February 22, 2022
Abandonment Date
May 20, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 20, 2024
Classes
005 042

Rights Holder

Crispr Therapeutics AG

99
Address
Baarerstrasse 14
ZUG V8 CH-6300
CH

Ownership History

Crispr Therapeutics AG

Original Applicant
99
ZUG V8 CH

Crispr Therapeutics AG

Owner at Publication
99
ZUG V8 CH

Legal Representation

Attorney
Tiffany D. Gehrke

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

26 events
Date Code Type Description Documents
May 20, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 20, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 28, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 28, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 17, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 15, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 15, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 15, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 5, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 3, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 3, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 3, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 19, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 22, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 19, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 19, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 19, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 19, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 19, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 11, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 17, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 22, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Cells for medical or clinical use; Pharmaceutical preparations being pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, pharmaceutical preparations being gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
Class 042
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Classification

International Classes
005 042